Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers
Authors
Article Information
Publication Timeline
- Published
Abstract
Early diagnosis of neurodegenerative diseases (NDs) such as Alzheimer’s (AD) and Parkinson’s (PD) is critically dependent on detecting specific protein biomarkers at very low concentrations. This study presents the design, fabrication, and characterization of a novel label-free electrochemical biosensor for ultrasensitive detection of key ND biomarkers (β-amyloid (Aβ), tau, and α-synuclein). A glassy carbon electrode (GCE) was modified with a nanocomposite of carboxyl graphene (CG), thionin, and electrodeposited Au nanoparticles (AuNPs) to immobilize a specific aptamer against tau protein. Electrochemical techniques (cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS)) were used to verify each modification step, and differential pulse voltammetry (DPV) was used to measure biomarker binding. The sensor yielded a linear response from 0.5 pM to 100 pM tau₃₈₁, with a detection limit (LOD) of ~0.5 pM and high sensitivity. These performance metrics are comparable to or exceed those of previously reported label-free biosensors. Cross-reactivity tests showed excellent selectivity against non-target proteins. The fabricated biosensor demonstrates rapid, reproducible detection of tau at clinically relevant levels, addressing key research questions: (1) Can a label-free electrochemical biosensor be engineered to detect neurodegenerative biomarkers at ultra-low concentrations? (2) What sensitivity and specificity can be achieved through nanomaterial-enhanced signal transduction? (3) How does this sensor performance compare with existing biosensing platforms? In answering these questions, this work contributes to the development of point-of-care ND diagnostics.
How to Cite
Olukotun, I. F., Titus-Okpanachi, A. O., Tiamiyu, R. T., & Inegbedion, E. (2025). Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers. International Journal of Medical and All Body Health Research, 6(2), 61-66. https://doi.org/10.54660/IJMBHR.2025.6.2.61-66
Olukotun, Ibukunoluwa Fikayo, et al. "Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers." International Journal of Medical and All Body Health Research, vol. 6, no. 2, 2025, pp. 61-66. https://doi.org/10.54660/IJMBHR.2025.6.2.61-66.
Olukotun, I. F., Titus-Okpanachi, A. O., Tiamiyu, R. T. and Inegbedion, E. (2025) 'Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers', International Journal of Medical and All Body Health Research, 6(2), pp. 61-66. doi: 10.54660/IJMBHR.2025.6.2.61-66.
Olukotun IF, Titus-Okpanachi AO, Tiamiyu RT, Inegbedion E. Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers. International Journal of Medical and All Body Health Research. 2025;6(2):61-66. doi:10.54660/IJMBHR.2025.6.2.61-66
Similar Articles
- Article: The impact of hospital malnutrition on patients in Somalia Vol 6, Issue 2 (2025)
- Therapeutic Efficacy Observation of Rituximab Combined With Low-Dose Glucocorticoids in the Treatment of Idiopathic Membranous Nephropathy Vol 6, Issue 2 (2025)
- Demographic, Lifestyle, and Clinical Profile of Diabetic Patients in Mosul’s Primary Health Care: A Cross-Sectional Study Vol 6, Issue 2 (2025)
- Comparative Diagnostic Performance of RIPASA, ALVARADO, and AIR Scoring Systems in Acute Appendicitis: A Retrospective Evaluation Using Traditional Metrics and XGBoost Algorithm Vol 6, Issue 2 (2025)
- The Clinical, Subclinical Characteristics and the Factor Associated of Intrauterine Fetal Death at ≥14 Weeks of Pregnancy Vol 6, Issue 2 (2025)
Find this Article on
Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASEA newly published article may take a few days to appear on these services.